Roche Holding AG Participation (ROG)

Currency in CHF
261.30
+7.20(+2.83%)
Closed·
ROG Scorecard
Full Analysis
Has raised its dividend for 28 consecutive years
Earnings results expected tomorrow
Fair Value
Day's Range
254.70261.60
52 wk Range
231.90313.80
Key Statistics
Bid/Ask
258.00 / 261.80
Prev. Close
254.1
Open
255.2
Day's Range
254.7-261.6
52 wk Range
231.9-313.8
Volume
928.59K
Average Volume (3m)
998.28K
1-Year Change
-9.28%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ROG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
300.66
Upside
+15.06%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Roche Holding AG Participation Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.

Employees
103249

Compare ROG to Peers and Sector

Metrics to compare
ROG
Peers
Sector
Relationship
P/E Ratio
25.0x19.8x−0.5x
PEG Ratio
−0.90−0.040.00
Price/Book
6.5x1.8x2.6x
Price / LTM Sales
3.3x3.1x3.2x
Upside (Analyst Target)
11.9%75.4%42.7%
Fair Value Upside
Unlock12.9%5.8%Unlock

Analyst Ratings

7 Buy
8 Hold
4 Sell
Ratings:
19 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 300.66
(+15.06% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 10.39%
Dividend Yield
3.82%
Industry Median 2.33%
Annualised payout
9.70
Paid annually
5-Years Growth
+1.51%
Growth Streak

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
-- / --
Revenue / Forecast
15.44B / 15.30B
EPS Revisions
Last 90 days

ROG Income Statement

People Also Watch

93.12
NOVN
+1.05%
558.40
ZURN
+0.54%
77.75
NESN
+0.31%
52.72
ABBN
+2.33%
606.60
ASML
+0.70%

FAQ

What Stock Exchange Does Roche Holding Participation Trade On?

Roche Holding Participation is listed and trades on the Switzerland Stock Exchange stock exchange.

What Is the Stock Symbol for Roche Holding Participation?

The stock symbol for Roche Holding Participation is "ROG."

What Is the Roche Holding Participation Market Cap?

As of today, Roche Holding Participation market cap is 208.00B.

What Is Roche Holding Participation's Earnings Per Share (TTM)?

The Roche Holding Participation EPS (TTM) is 10.39.

When Is the Next Roche Holding Participation Earnings Date?

Roche Holding Participation will release its next earnings report on 23 Jul 2025.

From a Technical Analysis Perspective, Is ROG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Roche Holding Participation Stock Split?

Roche Holding Participation has split 1 times.

How Many Employees Does Roche Holding Participation Have?

Roche Holding Participation has 103249 employees.

What is the current trading status of Roche Holding Participation (ROG)?

As of 23 Jul 2025, Roche Holding Participation (ROG) is trading at a price of 261.30, with a previous close of 254.10. The stock has fluctuated within a day range of 254.70 to 261.60, while its 52-week range spans from 231.90 to 313.80.

What Is Roche Holding Participation (ROG) Price Target According to Analysts?

The average 12-month price target for Roche Holding Participation is CHF300.66105, with a high estimate of CHF454 and a low estimate of CHF220. 7 analysts recommend buying the stock, while 4 suggest selling, leading to an overall rating of Neutral. The stock has an +15.06% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.